IFF has agreed to sell its Food Ingredients business to CVC Capital Partners for $4.3 billion, with proceeds primarily going towards debt reduction and reinvestment in its core segments. The business, generating $3.1 billion in sales and $430 million in EBITDA in 2025, covers specialty ingredients for multinational food and beverage manufacturers, including texturants and plant-based solutions. IFF will retain a 10% minority equity stake and a board seat in the new company, enabling them to participate in future growth.
CVC Capital Partners sees the acquisition as an opportunity to add a scaled food ingredients platform to its US portfolio, citing the business's strong position in an attractive sector with long-term growth trends. The deal, subject to regulatory approvals, is expected to close by the end of the second quarter of 2027. With the sale of their Food Ingredients business, IFF continues its strategy of streamlining its portfolio to drive innovation, R&D investment, and integration of biotechnology and naturals capabilities globally.
*This summary was generated using AI.
Read Full Article